Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Bio-Thera Solutions, Biogen, Daiichi Sankyo, Deciphera, Eisai, Ono, Peijia Medical, Racthera, Stada Arzneimittel, Sumitomo, Takeda, Telix.